Home › Kanser sa Ulo at Leeg
Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg na nagre-recruit sa U.S.
157 pag-aaral para sa Kanser sa Ulo at Leeg ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX30 pag-aaral
- New York City, NY23 pag-aaral
- Boston, MA23 pag-aaral
- Nashville, TN22 pag-aaral
- St. Louis, MO17 pag-aaral
- Pittsburgh, PA13 pag-aaral
- Dallas, TX13 pag-aaral
- Los Angeles, CA12 pag-aaral
- Chicago, IL12 pag-aaral
- Durham, NC11 pag-aaral
- Baltimore, MD11 pag-aaral
- Washington, DC11 pag-aaral
- Miami, FL10 pag-aaral
- San Antonio, TX10 pag-aaral
- Edison, NJ9 pag-aaral
- San Diego, CA9 pag-aaral
- Cleveland, OH9 pag-aaral
- San Francisco, CA9 pag-aaral
- Tampa, FL9 pag-aaral
- Philadelphia, PA9 pag-aaral
- Charleston, SC8 pag-aaral
- Portland, OR8 pag-aaral
- Columbus, OH8 pag-aaral
- New Haven, CT8 pag-aaral
- Rochester, MN7 pag-aaral
- Baldwin Park, CA7 pag-aaral
- Orlando, FL7 pag-aaral
- Aurora, CO6 pag-aaral
- Queens, NY6 pag-aaral
- Staten Island, NY6 pag-aaral
- New Rochelle, NY6 pag-aaral
- Mountain View, CA6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- Milwaukee, WI6 pag-aaral
- Arlington, VA6 pag-aaral
- Sacramento, CA5 pag-aaral
- Newark, NJ5 pag-aaral
- Birmingham, AL5 pag-aaral
- Seattle, WA5 pag-aaral
- Charlottesville, VA5 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona4 pag-aaral
- Arkansas3 pag-aaral
- California33 pag-aaral
- Colorado10 pag-aaral
- Connecticut10 pag-aaral
- Delaware3 pag-aaral
- District of Columbia5 pag-aaral
- Florida25 pag-aaral
- Georgia5 pag-aaral
- Illinois13 pag-aaral
- Iowa6 pag-aaral
- Kansas7 pag-aaral
- Kentucky6 pag-aaral
- Louisiana4 pag-aaral
- Maryland17 pag-aaral
- Massachusetts25 pag-aaral
- Michigan11 pag-aaral
- Minnesota11 pag-aaral
- Missouri18 pag-aaral
- Nebraska5 pag-aaral
- New Jersey14 pag-aaral
- New Mexico4 pag-aaral
- New York32 pag-aaral
- North Carolina15 pag-aaral
- Ohio17 pag-aaral
- Oklahoma7 pag-aaral
- Oregon8 pag-aaral
- Pennsylvania23 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina10 pag-aaral
- Tennessee25 pag-aaral
- Texas42 pag-aaral
- Utah6 pag-aaral
- Virginia15 pag-aaral
- Washington5 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02507141Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07741643Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07667400Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07741565Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06627270Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07631650Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06125743A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06319963Biospecimen Procurement for Head and Neck Disorders
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT03429036A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT05207098A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07418034Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07090499Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06096038cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03556228Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07059884Feasibility of Cough Skill Training in Individuals With Head and Neck Cancer
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07756684Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 90 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT00900419An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Nagre-recruitPhase 3
6 Months – 17 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06915727FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06788990SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07873450Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07901959Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06295731Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06710756Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.